Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Stwierdzono przednowotworowe lub nowotworowe zmiany w trzustce.
- •Pacjenci, którzy już są leczeni tymi metodami w ramach opieki klinicznej.
✗ Disqualifies
- •Pacjenci z innymi chorobami nowotworowymi w tym samym czasie lub w przeszłości.
- •Pacjenci, którzy nie mogą wyrazić świadomej zgody na udział.
- •Pacjenci, którzy nie będą mogli uczestniczyć w badaniu kontrolnym.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 30, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
The University of Texas Health Science Center at Houston
Houston, United States
Trial contact
Amatullah Alibhai, MBA
Nicole Fatheree, BBA
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/31/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.